Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bCalm
- Development stage
- Phase 4
- Lead developer
- NuLife Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**bCalm** is a NuLife Sciences oral nutraceutical dietary supplement marketed under the company's microvascular health and wellness portfolio, but the product-specific positioning identified in the provided context is for emotional health rather than a defined microvascular indication. The active ingredient is reported to correspond 100% to **inositol**, commonly described in supplement marketing as vitamin B8, and it is promoted to calm the mind and body naturally and support tranquility and overall wellness. Mechanistically, bCalm appears to function as an **inositol supplement** rather than a pharmaceutical drug with a validated single molecular target; any anxiolytic or metabolic effects would be attributed to inositol's role as an endogenous carbohydrate involved in phosphoinositide and second-messenger signaling, but no specific clinical development program or drug pipeline evidence was identified for bCalm.
- Brand names
- bCalm
- Other names
- inositolvitamin B8
02
Targets
SLC2A13 (Proton myo-inositol cotransporter (HMIT1))SLC5A3 (Sodium/myo-inositol cotransporter 1 (SMIT1))SLC5A11 (Sodium-coupled myo-inositol transporter 2 (SMIT2))5-HT (Serotonin receptors)
Beyond the preview
Go deeper on bCalm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bCalm.